|
Richard S. Schneider, Ph.D. was a General Partner of Domain Associates, a venture capital firm, from 1990 until his retirement in 1999. Domain manages over $900 million and invests in healthcare and biotechnology companies. Prior to joining Domain Associates, Dr. Schneider served as Vice President of 3i Ventures Corporation, a venture capital firm, from April 1986 to July 1990. From 1983 to 1989, he was President of Biomedical Consulting Associates. From 1967 to 1983, Dr. Schneider was Vice President and founder of Syva Company, a diagnostics company that was part of Syntex Corporation, a pharmaceutical company. Dr. Schneider is a Director of Landec Corporation, Selective Genetics, Inc., Sonosite, Inc., AvanViva, Inc., and MitoKor and serves on the advisory boards of two venture capital firms. Dr. Schneider holds a Ph.D. in organic chemistry from the University of Wisconsin, completed post-doctoral studies at the Massachusetts Institute of Technology, attended the Stanford Graduate School of Business and holds a B.S. degree in Chemistry from the University of California, Berkeley. | 